About us Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a
Experteer OverviewIn this role you will lead procurement for Primary Packaging & Devices at the corporate level, driving cost efficiency and strategic supplier partnerships. You will work within Global Direct Procurement to optimize spend and ensure
OverviewAre you ready to shape the future of sustainable industries? Join GEA and become part of a global team that’s driving innovation, excellence, and impact across the food, beverage, and process sectors. GEA is a leading
Location Vicofertile (PR) Responsibilities Trasmissione alle funzioni acquisti centrali e di divisione delle informazioni relative alle necessità di codici da approvvigionare, in termini di quantità e tempistiche. Collaborazione con tutti gli enti coinvolti per il monitoraggio
Project Engineer – PV Industry Location: Remote (Italy) About the Role Our client is seeking a highly motivated Project Engineer to join a leading international provider of innovative photovoltaic (PV) solutions. In this role, you will
EFSA Seconded National Experts Call 2025-2027 EFSA SECONDED NATIONAL EXPERTS CALL The European Food Safety Authority (EFSA) , based in Parma, Italy, is opening positions for Seconded National Experts (SNEs) across all Units and Departments. As
The Davines Group, founded in Parma in 1983, specializes in professional cosmetic products under the brands Davines for haircare and [ comfort zone ] for skincare. Led by Chairman Davide Bollati and CEO Anthony Molet, the
JOIN THE TEAM THAT’S POWERING PROGRESS Building cities. Driving commerce. Fueling Progress. For over 100 years, Allison has powered the vehicles and technology that move our world forward. What powers us? Our employees. From the first
Chiesi Global Rare Diseases Chiesi Global Rare Diseases is a Chiesi Group’s business unit established in February 2020 and focused on research, development and commercialization of treatments and patient support services for rare and ultra-rare disorders,